Effect of tadalafil on erectile dysfunction in male patients with diabetes mellitus
Author(s) -
Srdjan Popović,
Djordje Nale,
Marija Dabetic,
Dragana Matanović,
Vesna Dimitrijević-Srećković,
Gordana Milic,
Draško Gostiljac,
Svetlana Vujović,
Nebojša Antonijević,
Tanja Nišić,
Predrag Djordjević
Publication year - 2007
Publication title -
vojnosanitetski pregled
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.123
H-Index - 19
eISSN - 2406-0720
pISSN - 0042-8450
DOI - 10.2298/vsp0706399p
Subject(s) - tadalafil , medicine , erectile dysfunction , prostaglandin e1 , diabetes mellitus , erectile function , sildenafil , type 2 diabetes mellitus , urology , endocrinology
[corrected] During the first 10 years over 50% of diabetes patients develop erectile dysfunction (ED). It is more severe and resistant to therapy than in male patients with normal glucoregulation. The purpose of this pilot study was to estimate the tadalafil (Cialis) efficacy and safety in male patients with diabetes mellitus (DM), together with moderate to severe ED.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom